The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-institution experience with the pembrolizumab (PEM) Expanded Access Program (EAP).
 
Karen Mae Perdon
No Relationships to Disclose
 
Dae Won Kim
No Relationships to Disclose
 
Gener C Balmes
No Relationships to Disclose
 
VanAnh Trinh
No Relationships to Disclose
 
Susan E McIntyre
No Relationships to Disclose
 
Adi Diab
No Relationships to Disclose
 
Rodabe Navroze Amaria
No Relationships to Disclose
 
Sapna Pradyuman Patel
Consulting or Advisory Role - Amgen; Genentech/Roche; MD Anderson Cancer Center
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Prometheus (Inst); Reata Pharmaceuticals (Inst)
 
Patrick Hwu
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb; Genentech
 
Marihella James
No Relationships to Disclose
 
Ann Philip
No Relationships to Disclose
 
Anna Vardeleon
No Relationships to Disclose
 
Suzanne Cain
No Relationships to Disclose
 
Wen-Jen Hwu
Consulting or Advisory Role - Merck
Research Funding - Merck